
View larger version (48K):
[in this window]
[in a new window]
|
Fig. 2. Defective differentiation of lung cells in Ndst1–/– mice. Sections of wild-type (A,C,E,H,J,M,O,R,T,W) and Ndst1 mutant lungs (B,D,F,I,K,N,P,S,U,X) were immunostained with antibodies as indicated. Nuclei are stained with hematoxylin (A,B) or DAPI (C-F,H-K,O,P,R-U,W,X). The percentage of cells that stained with antibodies against SFTPC (G), AQP5 (L), CC10 (Q) and caveolin-1(V) were calculated from six sections from three lungs of each genotype at 16.5 d.p.c. and 18.5 d.p.c. (C-F) Labeling with antibodies against SFTPC indicates that there are fewer type II alveolar cells (red) in mutant lungs than in the wild type. (H-K) AQP5 staining reveals there are fewer type I alveolar cells or their precursor cells in mutant lungs than in the wild type. (M-P) Bronchioles in wild-type, as well as in mutant mice, are lined with CC10-immunoreactive Clara cells (brown in M,N; green in O,P). However, the bronchioles are smaller and less dilated in mutant lungs (P) than in normal littermates (O). (R-X) Caveolin-1 and SMA staining suggests that blood vessel structure is unchanged in Ndst1 mutant lungs. (Y) Real-time quantification of RNA transcripts of genes including Sftpa, Sftpb, Sftpc and Aqp5. **P<0.01. Bars represent means + s.d. Scale bars: 50 µm (C-F,H-K,O,P,R-U,W,X), 100 µm (A,B), 200 µm (M,N).
|